ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
China · Delayed Price · Currency is CNY 33.20
-1.17 (-3.40%)
Sep 24, 2026, 3:04 PM CST
SHE:300723 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,200 | 515.38 | 468.97 | 422.52 | 645.6 | 1,075 |
Short-Term Investments | - | - | - | 1 | - | - |
Trading Asset Securities | 145.25 | - | 4.75 | 40.44 | 72.19 | 15.03 |
Cash & Short-Term Investments | 1,346 | 515.38 | 473.72 | 463.96 | 717.78 | 1,090 |
Cash Growth | 24.60% | 8.79% | 2.10% | -35.36% | -34.15% | 47.50% |
Accounts Receivable | 196.33 | 242.2 | 351.1 | 451.38 | 397.75 | 243.39 |
Other Receivables | 37.93 | 40.1 | 11.24 | 12.48 | 12.4 | 27.16 |
Receivables | 234.27 | 282.31 | 362.34 | 463.86 | 410.15 | 270.55 |
Inventory | 207.09 | 215.91 | 287.13 | 346.44 | 178.02 | 114.97 |
Prepaid Expenses | 6.87 | 2.38 | 22.68 | 1.02 | - | - |
Other Current Assets | 63.23 | 85 | 112.02 | 84.58 | 105.37 | 88.02 |
Total Current Assets | 1,857 | 1,101 | 1,258 | 1,360 | 1,411 | 1,564 |
Property, Plant & Equipment | 1,722 | 1,790 | 1,928 | 1,799 | 1,686 | 1,043 |
Long-Term Investments | 278.15 | 525.57 | 583.44 | 633.55 | 384.44 | 408.01 |
Goodwill | 0.26 | 0.26 | 0.26 | 11.28 | 11.28 | 11.28 |
Other Intangible Assets | 367.49 | 390.19 | 428.46 | 446.79 | 460.97 | 460.42 |
Long-Term Deferred Tax Assets | 153.83 | 137.5 | 129.13 | 54.34 | 47.32 | 36.71 |
Long-Term Deferred Charges | 89.06 | 89.09 | 59.37 | 56.1 | 59.53 | 58.53 |
Other Long-Term Assets | 19.81 | 8.98 | 17.37 | 44.78 | 37.08 | 146.58 |
Total Assets | 4,488 | 4,042 | 4,404 | 4,405 | 4,098 | 3,728 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 81.64 | 82.04 | 107.84 | 202.4 | 84.83 | 40.65 |
Accrued Expenses | 26.17 | 49.06 | 48.18 | 126.28 | 77.65 | 73.15 |
Short-Term Debt | 765.15 | 520.08 | 1,000 | 550 | 550 | 851.66 |
Current Portion of Long-Term Debt | 60.46 | 181.34 | 60.29 | 40 | 2.23 | 1.56 |
Current Portion of Leases | 0.9 | 1.79 | 17.63 | 26.39 | 25.49 | 23.06 |
Current Income Taxes Payable | - | - | - | 37.81 | 27.93 | 6.41 |
Current Unearned Revenue | 11.89 | 36.57 | 38.8 | 48.37 | 110.36 | 20.99 |
Other Current Liabilities | 303.52 | 264.77 | 459.5 | 457.73 | 330.37 | 188.21 |
Total Current Liabilities | 1,250 | 1,136 | 1,732 | 1,489 | 1,209 | 1,206 |
Long-Term Debt | 1,225 | 1,368 | 610 | 160 | 531.42 | 270.45 |
Long-Term Leases | 1.43 | 1.43 | 2.8 | 26.03 | 58.52 | 82.33 |
Long-Term Unearned Revenue | 114.32 | 108.96 | 87.54 | 83.34 | 75.76 | 84.45 |
Long-Term Deferred Tax Liabilities | 17.59 | 21.14 | 35.49 | 49.01 | 58.09 | 66.82 |
Total Liabilities | 2,608 | 2,636 | 2,468 | 1,807 | 1,933 | 1,710 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 451.69 | 451.69 | 451.69 | 454.14 | 288.08 | 288.03 |
Additional Paid-In Capital | 600.24 | 592.8 | 682.13 | 814.15 | 542.26 | 570.59 |
Retained Earnings | 949.22 | 464.49 | 802.29 | 1,437 | 1,309 | 1,075 |
Treasury Stock | -155.73 | -139.63 | -57.66 | -182.82 | -192.6 | -169 |
Comprehensive Income & Other | - | - | - | - | 104.82 | 110.14 |
Total Common Equity | 1,845 | 1,369 | 1,878 | 2,522 | 2,051 | 1,874 |
Minority Interest | 34.47 | 37.34 | 57.43 | 75.83 | 114.59 | 144.07 |
Shareholders' Equity | 1,880 | 1,407 | 1,936 | 2,598 | 2,166 | 2,018 |
Total Liabilities & Equity | 4,488 | 4,042 | 4,404 | 4,405 | 4,098 | 3,728 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 2,053 | 2,073 | 1,691 | 802.43 | 1,168 | 1,229 |
Net Cash (Debt) | -707.35 | -1,558 | -1,217 | -338.46 | -449.87 | -139.01 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.57 | -3.45 | -2.69 | -0.75 | -1.04 | -0.33 |
Filing Date Shares Outstanding | 448.53 | 451.91 | 451.65 | 449.03 | 424.45 | 426.18 |
Total Common Shares Outstanding | 448.53 | 451.91 | 451.65 | 449.03 | 424.45 | 426.18 |
Working Capital | 607.31 | -34.66 | -474.5 | -129.13 | 202.47 | 357.9 |
Book Value Per Share | 4.11 | 3.03 | 4.16 | 5.62 | 4.83 | 4.40 |
Tangible Book Value | 1,478 | 978.9 | 1,450 | 2,064 | 1,579 | 1,403 |
Tangible Book Value Per Share | 3.29 | 2.17 | 3.21 | 4.60 | 3.72 | 3.29 |
Buildings | 1,217 | 1,217 | 1,180 | 1,039 | 615.95 | 75.71 |
Machinery | 1,096 | 1,093 | 981.26 | 820.5 | 272.02 | 244.21 |
Construction In Progress | 12.27 | 8.09 | 141.94 | 164.02 | 904.37 | 783.68 |